Prevention of Haemophilus influenzae type b disease: past success and future challenges.
about
Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old.Vaccine-preventable infections in Systemic Lupus Erythematosus.Bacterial meningitis in Malawian adults, adolescents, and children during the era of antiretroviral scale-up and Haemophilus influenzae type b vaccination, 2000-2012.Aerosol-based efficient delivery of telithromycin, a ketolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections.
P2860
Prevention of Haemophilus influenzae type b disease: past success and future challenges.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Prevention of Haemophilus influenzae type b disease: past success and future challenges.
@ast
Prevention of Haemophilus influenzae type b disease: past success and future challenges.
@en
type
label
Prevention of Haemophilus influenzae type b disease: past success and future challenges.
@ast
Prevention of Haemophilus influenzae type b disease: past success and future challenges.
@en
prefLabel
Prevention of Haemophilus influenzae type b disease: past success and future challenges.
@ast
Prevention of Haemophilus influenzae type b disease: past success and future challenges.
@en
P2860
P356
P1476
Prevention of Haemophilus influenzae type b disease: past success and future challenges.
@en
P2093
Aruna Chandran
James P Watt
P2860
P304
P356
10.1586/14760584.4.6.819
P577
2005-12-01T00:00:00Z